DrugDashboards

Lubiprostone

Lubiprostone · LUBIPROSTONE 24 ug/1 · Capsule · Patheon Softgels Inc.

NDC 10888-5126-01 · 20000 CAPSULE in 1 BOX · DRUG FOR FURTHER PROCESSING · View full market →

Bulk ingredient — not a finished product

This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.

Medicare Part D

This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for lubiprostone (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
TE code
Approval date
Patents / exclusivity

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Lubiprostone (Capsule)

LabelerStrengthFirst seenLast seen
Asclemed USA, Inc.LUBIPROSTONE 8 ug/1Jul 15, 2026Sep 2, 2026
Asclemed USA, Inc.LUBIPROSTONE 24 ug/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.LUBIPROSTONE .008 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.LUBIPROSTONE .024 mg/1Jul 15, 2026Sep 2, 2026
Northstar Rx LLCLUBIPROSTONE .024 mg/1Jul 15, 2026Sep 2, 2026
Northstar Rx LLCLUBIPROSTONE .008 mg/1Jul 15, 2026Sep 2, 2026
Patheon Softgels Inc.LUBIPROSTONE 24 ug/1Jul 15, 2026Sep 2, 2026
Patheon Softgels Inc.LUBIPROSTONE 8 ug/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedLUBIPROSTONE 8 ug/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedLUBIPROSTONE 24 ug/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals USA Inc.LUBIPROSTONE 8 ug/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals USA Inc.LUBIPROSTONE 24 ug/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Lubiprostone — NDC 10888-5126-01," retrieved September 3, 2026, https://drugdashboards.com/drug/10888512601.

Free to cite with attribution — see how the data is put together.